NVCT logo

Nuvectis Pharma, Inc. (NVCT)

Profile

Full Name

Nuvectis Pharma, Inc.

Ticker

NASDAQ: NVCT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 4, 2022

Indexes

Not included

Website

https://www.nuvectis.com

Employees

13

Key Details

Price

$6.01(1.52%)

Market Cap

$153.00M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$1.11(22.41% YoY)

PE Ratio

-

Next earnings date

Nov 4, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $6.01
    NVCT price is $6.01

    30-Day Relative Volume

    1.43
    NVCT 30-day relative volume is 1.43

    Price Performance

    Price Most Recent Change

    +1.52%
    NVCT price was up +1.52% on Oct 23, 2025

    Price YTD Change

    +11.09%
    NVCT price is up +11.09% since January 1st

    Price 1-Year Change

    -29.29%
    NVCT price is down -29.29% year-on-year

    Price 3-Year Change

    -14.75%
    NVCT price is down -14.75% over the past 3 years

    Price Range

    Price All-Time High

    $20.92
    NVCT price is currently -71.27% below its historical high of $20.92

    Price 3-Year Low

    $4.44
    NVCT price is currently +35.36% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $153.00M
    NVCT market cap is $153.00 million

    Market Cap 3-Year Change

    +48.21%
    NVCT market cap is up +48.21% over the past 3 years

    Market Cap All-Time High

    $294.54M
    NVCT market cap is currently -48.06% below its historical high of $294.54 million

    Market Cap Sector Percentile

    45.61%
    NVCT market cap is higher than 45.61% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +34.09%
    NVCT shares outstanding is up +34.09% year-on-year

    Shares Outstanding 3-Year Change

    +73.86%
    NVCT shares outstanding is up +73.86% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.04
    NVCT beta is 1.04

    200-day SMA

    $7.60
    NVCT price is currently -20.91% below its 200-day simple moving average

    50-day SMA

    $6.25
    NVCT price is currently -3.91% below its 50-day simple moving average

    14-Day RSI

    45.67
    NVCT 14-day relative strength index is 45.67

    Volume

    1.43
    NVCT 30-day relative volume is 1.43

    ATR

    $0.30
    NVCT average true range is $0.30

    10-day Historical Volatility

    32.91%
    NVCT 10-day historical volatility is 32.91%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    NVCT annual revenue is $0.00

    Revenue Analysts Estimate

    -
    NVCT annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    NVCT annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.75%
    NVCT annual revenue is higher than 28.75% of companies in Healthcare sector

    EPS

    EPS

    -$1.11
    NVCT annual earnings per share is -$1.11

    EPS Analysts Estimate

    -$1.05
    NVCT annual earnings per share is currently -5.24% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +22.41%
    NVCT annual earnings per share is up +22.41% year-on-year

    EPS Sector Percentile

    53.93%
    NVCT annual earnings per share is higher than 53.93% of companies in Healthcare sector

    Profit

    Gross Profit

    $0.00
    NVCT annual gross profit is $0.00

    Gross Margin

    -
    NVCT annual gross profit margin value is unknown

    Operating Profit

    -$19.85M
    NVCT annual operating income is -$19.85 million

    Operating Margin

    -
    NVCT annual operating profit margin value is unknown

    Net Income

    -$19.00M
    NVCT annual net profit is -$19.00 million

    Net Margin

    -
    NVCT annual net profit margin value is unknown

    Expenses

    Total Expenses

    $19.00M
    NVCT annual total expenses is $19.00 million

    Operating Expenses

    $19.85M
    NVCT annual total operating expenses is $19.85 million

    Cost Of Goods Sold

    $0.00
    NVCT annual cost of goods sold is $0.00

    Selling, General & Administrative Expenses

    $0.00
    NVCT annual SG&A is $0.00

    Depreciation & Amortization

    -
    NVCT annual D&A value is unknown

    Interest Expense

    $0.00
    NVCT annual interest expense is $0.00

    Income Tax

    $0.00
    NVCT annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$19.85M
    NVCT annual earnings before interest & taxes is -$19.85 million

    EBITDA

    -$19.85M
    NVCT annual EBITDA is -$19.85 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $18.61M
    NVCT annual total assets is $18.61 million

    Non Current Assets

    $0.00
    NVCT annual long term assets is $0.00

    Current Assets

    $18.61M
    NVCT annual total current assets is $18.61 million

    Cash and Cash Equivalents

    $18.53M
    NVCT annual cash & cash equivalents is $18.53 million

    Accounts Receivable

    -
    NVCT annual accounts receivable value is unknown

    Inventory

    $0.00
    NVCT annual inventory is $0.00

    Liabilities

    Total Liabilities

    $8.89M
    NVCT annual total liabilities is $8.89 million

    Long Term Liabilities

    $0.00
    NVCT annual total long term liabilities is $0.00

    Current Liabilities

    $8.89M
    NVCT annual current liabilities is $8.89 million

    Accounts Payable

    $2.50M
    NVCT annual accounts payable is $2.50 million

    Debt

    Total Debt

    $0.00
    NVCT annual total debt is $0.00

    Total Debt 1-Year Change

    0%
    NVCT annual total debt has remained unchanged year-on-year

    Long Term Debt

    $0.00
    NVCT annual long term debt is $0.00

    Short Term Debt

    $0.00
    NVCT annual short term debt is $0.00

    Equity & Capital

    Shareholders Equity

    $9.71M
    NVCT annual stockholders equity is $9.71 million

    Book Value

    $9.71M
    NVCT annual book value is $9.71 million

    Retained Earnings

    -$73.25M
    NVCT annual retained earnings is -$73.25 million

    Working Capital

    $9.71M
    NVCT annual working capital is $9.71 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$12.25M
    NVCT annual cash from operations is -$12.25 million

    Cash From Operations 1-Year Change

    +23.24%
    NVCT annual cash from operations is up +23.24% year-on-year

    Cash From Investing

    $0.00
    NVCT annual cash from investing is $0.00

    Cash From Investing 1-Year Change

    0%
    NVCT annual cash from investing has remained unchanged year-on-year

    Cash From Financing

    $11.65M
    NVCT annual cash from financing is $11.65 million

    Cash From Financing 1-Year Change

    -22.75%
    NVCT annual cash from financing is down -22.75% year-on-year

    CAPEX

    CAPEX

    $0.00
    NVCT annual capital expenditures is $0.00

    CAPEX 1-Year Change

    0%
    NVCT annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free Cash Flow

    -$12.25M
    NVCT annual free cash flow is -$12.25 million

    Free Cash Flow 1-Year Change

    +23.24%
    NVCT annual free cash flow is up +23.24% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    NVCT annual gross profit margin value is unknown

    Operating Margin

    -
    NVCT annual operating profit margin value is unknown

    Net Margin

    -
    NVCT annual net profit margin value is unknown

    ROA & ROE

    ROA

    -100.55%
    NVCT annual return on assets is -100.55%

    ROE

    -173.41%
    NVCT annual return on equity is -173.41%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    NVCT price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    NVCT price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    9.07
    NVCT price to book ratio is 9.07

    PB Ratio Sector Percentile

    86.45%
    NVCT price to book ratio is higher than 86.45% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    NVCT price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    NVCT price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $126.20M
    NVCT enterprise value is $126.20 million

    Enterprise Value Sector Percentile

    47.56%
    NVCT enterprise value is higher than 47.56% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -5.49
    NVCT EV/EBITDA is -5.49

    EV/EBITDA Sector Percentile

    23.75%
    NVCT EV/EBITDA is higher than 23.75% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.09
    NVCT annual current ratio is 2.09

    Quick Ratio

    2.09
    NVCT annual quick ratio is 2.09

    Leverage

    Debt To Equity

    0.00
    NVCT annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    NVCT annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    NVCT piotroski f-score value is unknown

    Altman Z-Score

    1.92
    NVCT altman z-score is 1.92

    Analyst ratings

    Recent major analysts updates

    Aug 4, 25 HC Wainwright & Co.
    Buy
    Apr 30, 25 HC Wainwright & Co.
    Buy
    Apr 2, 25 Maxim Group
    Buy
    Mar 17, 25 Laidlaw & Co.
    Buy
    Feb 25, 25 HC Wainwright & Co.
    Buy
    Aug 6, 24 HC Wainwright & Co.
    Buy
    May 8, 24 HC Wainwright & Co.
    Buy
    Sep 15, 23 HC Wainwright & Co.
    Buy
    Mar 7, 23 HC Wainwright & Co.
    Buy
    Feb 10, 23 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with NVCT included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Nuvectis Pharma, Inc.?
    • Does Nuvectis Pharma, Inc. pay dividends?
    • What sector is Nuvectis Pharma, Inc. in?
    • What industry is Nuvectis Pharma, Inc. in?
    • What country is Nuvectis Pharma, Inc. based in?
    • When did Nuvectis Pharma, Inc. go public?
    • Is Nuvectis Pharma, Inc. in the S&P 500?
    • Is Nuvectis Pharma, Inc. in the NASDAQ 100?
    • Is Nuvectis Pharma, Inc. in the Dow Jones?
    • When was Nuvectis Pharma, Inc.'s last earnings report?
    • When does Nuvectis Pharma, Inc. report earnings?

    What is the ticker symbol for Nuvectis Pharma, Inc.?

    The ticker symbol for Nuvectis Pharma, Inc. is NASDAQ:NVCT

    Does Nuvectis Pharma, Inc. pay dividends?

    No, Nuvectis Pharma, Inc. does not pay dividends

    What sector is Nuvectis Pharma, Inc. in?

    Nuvectis Pharma, Inc. is in the Healthcare sector

    What industry is Nuvectis Pharma, Inc. in?

    Nuvectis Pharma, Inc. is in the Biotechnology industry

    What country is Nuvectis Pharma, Inc. based in?

    Nuvectis Pharma, Inc. is headquartered in United States

    When did Nuvectis Pharma, Inc. go public?

    Nuvectis Pharma, Inc.'s initial public offering (IPO) was on February 4, 2022

    Is Nuvectis Pharma, Inc. in the S&P 500?

    No, Nuvectis Pharma, Inc. is not included in the S&P 500 index

    Is Nuvectis Pharma, Inc. in the NASDAQ 100?

    No, Nuvectis Pharma, Inc. is not included in the NASDAQ 100 index

    Is Nuvectis Pharma, Inc. in the Dow Jones?

    No, Nuvectis Pharma, Inc. is not included in the Dow Jones index

    When was Nuvectis Pharma, Inc.'s last earnings report?

    Nuvectis Pharma, Inc.'s most recent earnings report was on May 6, 2025

    When does Nuvectis Pharma, Inc. report earnings?

    The next expected earnings date for Nuvectis Pharma, Inc. is November 4, 2025
    On this page